BioNTech (BNTX) PT Lowered to $177 at Goldman Sachs
Tweet
Share
E-mailGet Alerts BNTX Hot Sheet
Price: $103.13 +1.17%
Rating Summary:
17 Buy, 6 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 4 | Down: 9 | New: 31
Rating Summary:
17 Buy, 6 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 4 | Down: 9 | New: 31
Join SI Premium – FREE
Goldman Sachs analyst Chris Shibutani lowered the price target on BioNTech (NASDAQ: BNTX) to $177.00 (from $200.00) while maintaining a Neutral rating.
You May Also Be Interested In
- Sprinklr Inc (CXM) PT Raised to $7.50 at Cantor Fitzgerald
- GitLab Inc (GTLB) PT Raised to $55 at TD Cowen
- ONEOK Inc (OKE) PT Raised to $104 at Truist Securities
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
